聚-4-羟基丁酸网片与脱细胞真皮基质在组织扩张器乳房重建中的比较
本研究比较了聚-4-羟基丁酸(P4HB)网片与脱细胞真皮基质(ADM)在即刻胸肌后扩张器乳房重建中的效果,P4HB组感染率较低但无统计学差异,引流管拔除时间显著缩短。单因素分析显示P4HB组主要并发症、血清肿、感染等风险比值均降低。
要点
- P4HB网片组引流管拔除时间显著短于ADM组(15天 vs 18天,P=0.008)
- P4HB组总体感染率11% vs ADM组17%,差异无统计学意义(P=0.18)
- 单因素分析中P4HB组主要并发症、血清肿、感染等风险比值均下降
核心结论
- P4HB网片是扩张器乳房重建中ADM的安全替代品,趋势显示感染、血清肿和设备取出率降低。
主要发现
- P4HB组与ADM组基线特征相似。
- P4HB组感染率11% vs ADM组17%,差异无统计学意义(P=0.18)。
- P4HB组引流管拔除时间显著更短(15天 vs 18天,P=0.008)。
- 血清肿发生率两组无差异(0.9% vs 3%,P=0.43)。
- 两组接受外照射放疗(22% vs 24%)和化疗(48% vs 45%)的比例相似。
关键数值与推荐
- 单因素分析中,使用P4HB的所有比值比均降低:主要并发症OR=0.55,血清肿OR=0.17,感染OR=0.59,再手术OR=0.78,皮肤坏死OR=0.77。
临床怎么用
- 在即刻胸肌后扩张器乳房重建中,可考虑使用P4HB网片替代ADM,可能缩短引流管留置时间并降低部分并发症风险。
局限性
- 样本量较小,仅为初始患者系列,结果需更大规模研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acellular dermal matrix (ADM) is commonly used during immediate expander-based breast reconstruction, with potential advantages of greater intraoperative expansion, decreased time to complete expansion, and decreased rates of capsular contracture. However, ADM is associated with increased infection rate, seroma, and subsequent reconstructive failure. Poly-4-hydroxybutyric acid (P4HB) mesh is a large pore, biosynthetic scaffold shown to fully resorb and incorporate host tissues within 18 months. We sought to compare outcomes between the use of P4HB and ADM in immediate retropectoral expander-based reconstruction. METHODS: One hundred ninety-two consecutive cases (107 patients) of breast reconstruction using ADM were compared with a subsequent cohort of 112 cases (62 patients) using P4HB mesh. In all patients, reconstruction was performed immediately after mastectomy by a single surgeon, and outcomes were compared between groups. RESULTS: Baseline characteristics were similar between the P4HB and ADM groups. Overall infection rates were lower, but not significantly with P4HB (11% vs 17%, P = 0.18). Time to drain removal was significantly lower with P4HB (15 vs 18 days, P = 0.008), although there was no difference in rates of seroma (0.9% vs 3%, P = 0.43). Similar numbers of patients underwent external beam radiation (22% vs 24%) and received chemotherapy in each group (48% vs 45%). By univariate analysis, all odds ratios were decreased with use of P4HB, including risk of major complications (0.55), seroma (0.17), infection (0.59), need for reoperation (0.78), and skin necrosis (0.77). CONCLUSIONS: Initial findings suggest P4HB mesh to be a safe alternative to ADM in expander-based breast reconstruction, with trends toward decreased rates of infection, seroma, and need for device removal using P4HB mesh. Although our results are limited to a small series of initial patients, P4HB mesh may be a promising novel technique to decrease complications inherent to use of ADM at a reduced material cost.
引用
- Levy AS, Bernstein JL, Xia JJ, et al. Poly-4-Hydroxybutyric Acid Mesh Compares Favorably With Acellular Dermal Matrix in Tissue Expander-Based Breast Reconstruction. Ann Plast Surg. 2020. PMID: 32243319. doi:10.1097/SAP.0000000000002339
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。